Allergan
Pharmaceutical company Allergan recently announced it had received a Complete Response Letter from the US Food and Drug Administration (FDA) for its Prior Approval Supplement (PAS) for Restasis® (Cyclosporine Ophthalmic Emulsion) 0.05%, Multi-Dose Preservative-Free (MDPF) presentation.
The FDA reportedly asked for additional CMC information for the Multi-Dose Preservative-Free (MDPF) bottle, which according to Allergan has a patented uni-directional valve and air filter technology. Allergan is reportedly compiling the data requested and will respond to the FDA in a timely manner.
Click here to read the full press release.
Allergan also recently announced it had received an Energy Star 2016 Partner of the Year — Sustained Excellence Award from the US Environmental Protection Agency (EPA).
The award was given to Allergan for its continued improvement of energy performance and leadership in energy management in both the pharmaceutical and industrial sectors. As an Energy Star partner since 1996, this is the fifth time Allergan is being recognized by the EPA.
Click here to read the full press release.